Concepedia

Author

Karen Price

Bristol-Myers Squibb (United States)ORCID

Also Known As

K Price, K. Price, K.D. Price, KD Price, Karen D. Price, Karen Price, Price, Karen D

41

Publications

1.5K

Citations

12

H-Index

34

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Emory UniversityEmory HealthcareThe Bristol-Myers Squibb Children's HospitalPfizer (United States)
KP

About

Karen Price is an author at Bristol-Myers Squibb (United States) specializing in immunotherapy, medicine, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

119

2

Immunology

5

5

119

3

Allergy

2

2

23

4

Cell Biology

1

1

11

5

Clinical Immunology

1

1

11

Karen Price

×

10

Publications

1.1K

Citations

10

H-Index

YearCitations

Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties

Christian P. Larsen, Thomas C. Pearson, Andrew Adams,

American Journal of Transplantation

2005

707

Development of a Chimeric Anti-CD40 Monoclonal Antibody That Synergizes with LEA29Y to Prolong Islet Allograft Survival

Andrew Adams, Nozomu Shirasugi, Thomas R. Jones,

The Journal of Immunology

2005

181

Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection

Soo‐Chan Kim, W. Wakwe, Laura Higginbotham,

American Journal of Transplantation

2017

92

Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodies

Shujie J. Wang, Steven T. Wu, Jochem Gokemeijer,

Analytical and Bioanalytical Chemistry

2011

61

Survey results on the use of the tissue cross-reactivity immunohistochemistry assay

Jeanine L. Bussiere, Michael W. Leach, Karen Price,

Regulatory Toxicology and Pharmacology

2010

24

Nipocalimab, an immunoselective FcRn blocker that lowers IgG and has unique molecular properties

Nilufer P. Seth, Rui Xu, Matthew DuPrie,

mAbs

2025

20

Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR × NZB)F1 murine model

Matthew L. Stoll, Karen Price, Christopher Silvin,

Journal of Autoimmunity

2007

13

Methods: Implementation of<i>in vitro</i>and<i>ex vivo</i>phagocytosis and respiratory burst function assessments in safety testing

Wendy Freebern, Tammy Bigwarfe, Karen Price,

Journal of Immunotoxicology

2012

12

Abstract LB-B33: Nonclinical safety evaluation of two distinct second generation variants of anti-CTLA4 monoclonal antibody, ipilimumab, in monkeys

Karen Price, Frank Simutis, Anthony M. Fletcher,

Molecular Cancer Therapeutics

2018

11

Abstract 4552: Preclinical characterization of BMS-986218, a novel nonfucosylated anti–CTLA-4 antibody designed to enhance antitumor activity

John Engelhardt, Rahima Akter, John T. Loffredo,

Cancer Research

2020

11

Page 1